Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
09/2003
09/04/2003US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166637 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9H-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
09/04/2003US20030165711 Novel organometallic luminescent materials and organic electroluminescent device containing same
09/03/2003EP1341403A1 Luminescent element material and luminescent element comprising the same
09/03/2003EP1340744A2 Hiv protease inhibitors
09/03/2003EP1339701A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
09/03/2003EP1339690A1 N-type calcium channel antagonists for the treatment of pain
09/03/2003EP1339689A1 N-type calcium channel antagonists for the treatment of pain
09/03/2003EP1339688A1 N-type calcium channel antagonists for the treatment of pain
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003EP1339663A2 Naphthalene derivatives
09/03/2003EP1200408B1 Bonding agent
09/03/2003CN1440400A Bicyelyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
09/03/2003CN1120157C Substituted quinoline-2-carboxylic acid amidesuand their preparation and their use as medicaments and intermediate products
09/03/2003CN1120156C N,N'-bis (quinolin-4-yl-diamine derive and their preparation and their use as antimalarials
09/02/2003US6613942 Glucagon antagonists/inverse agonists
09/02/2003US6613805 For therapy and prophylaxis of neurodegenerative diseases such as Alzheimer's disease, Down's syndrome, Parkinson's disease, Creutzfeldt-Jacob disease, amyotrophic sclerosis on lateral fasciculus, multiple sclerosis, and neurological disorders
09/02/2003US6613803 Treating, preventing or ameliorating pain
09/02/2003US6613770 Quinoline derivatives as NK-2 and NK-3 receptor ligands
09/02/2003US6613764 Aspartic protease inhibitors
08/2003
08/28/2003WO2003070717A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
08/28/2003WO2003070691A1 N-hydroxycarboxamide derivative
08/28/2003WO2003070277A1 Antipruritics
08/28/2003WO2003070244A1 Antagonist of melanin concentrating hormone and their uses
08/28/2003US20030162967 Having antithrombotic effect; fortherapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses; reversible inhibitors of blood clotting enzymes factor Xa and/or factor VIIa
08/28/2003US20030162811 Heterocyclic amines such as 4-(3'-Thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
08/28/2003US20030162799 Squaric acid derivatives
08/28/2003US20030162777 Administering a biheterocyclic compounds containing aminocarbonyl, aminothiocarbonyl or aminosulfonyl group for treating neuromuscular dysfunction of the lower urinary tract in a mammal in need of such treatment
08/28/2003US20030162761 Androgen receptor targeting agents which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor
08/27/2003EP1338336A1 Catalysts comprising n-substituted cyclic imides and processes for preparing organic compounds with the catalysts
08/27/2003EP1337529A2 Heterocyclylalkyl piperidine derivatives, their preparation and compositions containing same
08/27/2003EP1337524A1 Substituted quinolines as antitumor agents
08/27/2003EP1337523A2 2,4-substituted pyridine derivatives
08/27/2003EP1337513A1 4-substituted quinolines as antitumor agents
08/27/2003EP1337508A1 Preparation of sodium-hydrogen exchanger type-1 inhibitors
08/27/2003CN1438998A Quinolinyl and benzothiazolyc PPAR-gamma modulators
08/27/2003CN1119336C Novel compounds with analgesic effect
08/27/2003CN1119331C Improved process for preparation of halo-4-phenoxyquinolines
08/27/2003CN1119149C 10,11 methanodibenzosuberane derivatives used as chemo sensitizing agents
08/26/2003US6610854 Reacting (Z)-5-Fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl) indenylacetamide with hydrochloric acid to produce (Z)-5-fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl)indenylacetamide hydrochloride
08/26/2003US6610747 Phenoxybenzylamine derivatives as SSRIs
08/26/2003US6610715 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
08/26/2003US6610702 Ammonium salts of inositol hexaphosphate, and uses thereof
08/26/2003US6610678 Corticotropin-releasing factor antagonists; treating endocrine, psychiatric or neurologic disorders
08/23/2003CA2473075A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
08/21/2003WO2003069350A2 Small molecule modulators of apoptosis
08/21/2003WO2003068771A1 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
08/21/2003WO2003068760A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
08/21/2003WO2003068749A1 Vanilloid receptor modulators
08/21/2003WO2003068748A1 Novel pyridine- and quinoline-derivatives
08/21/2003WO2003068236A1 Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptors
08/21/2003WO2003068230A1 Substituted pyridinones as modulators of p38 map kinase
08/21/2003WO2003068229A1 Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
08/21/2003WO2003068212A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/21/2003WO2002002512A3 Compounds to treat alzheimer's disease
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158236 Treating, e.g., an HIV infection.
08/21/2003US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders
08/21/2003US20030158202 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
08/21/2003US20030158197 Certain alkylene diamine-substituted heterocycles
08/21/2003US20030158179 Quinoline derivatives
08/21/2003US20030158178 Heterocyclic retinoid compounds
08/21/2003US20030158177 Treating or preventing obesity
08/21/2003US20030156244 Electron-driven chirality switches
08/21/2003CA2476446A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/20/2003EP1335901A1 Pharmaceutically active sulfanilide derivatives
08/20/2003EP1150944B1 N2-phenylamidine derivatives
08/20/2003EP0765313B1 N,n'-bis(quinolin-4-yl)-diamine derivatives, their preparation and their use as antimalarials
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/20/2003CN1118456C 1,2-dihydro-2-oxoquinoline derivatives
08/19/2003US6608084 Treatment of human or non-human animal patient suffering from, or subject to, condition which can be ameliorated by administration of inhibitor of alpha 4 beta 1 mediated cell adhesion
08/19/2003US6608083 Treatment and/or prophylaxis of convulsive disorders, renal disorders, urinary incontinence, ocular inflammation, eating disorders, inflammatory pain, allergic rhinitis, psoriasis,neurodegenerative disorders, Huntington's disease,
08/19/2003US6608066 Tissue factor antagonists and methods of use thereof
08/19/2003US6608061 Bisaryl compound and medicament for cancer treatment comprising the same
08/19/2003CA2085347C Novel cyclic aminophenylacetic acid derivative, production therof, and immune response modulator containing the same as active ingredient
08/14/2003WO2003066604A2 Novel aryl- and heteroarylpiperazines
08/14/2003WO2003066598A1 Novel anhydrous amorphous forms of montelukast sodium salt
08/14/2003WO2003066597A2 Guanidino compounds
08/14/2003WO2003066575A1 Process for the synthesis of n-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids
08/14/2003WO2003066574A1 Aromatic amino acid derivatives and medicinal compositions
08/14/2003WO2003066055A1 Quinoline derivatives as npy antagonists
08/14/2003WO2003065989A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
08/14/2003WO2003024955A3 Small molecule inhibitors of caspases
08/14/2003WO2002058703A3 The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers
08/14/2003US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
08/14/2003US20030153763 Indolinyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydro isoquinolinyl, benz(cd)indolinyl and 5,6-dihydrophen anthridinyl compounds; treating neurodegenerative disorders
08/14/2003US20030153597 Therapeutic treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease, nervous system disorders and cardiovascular disorders
08/14/2003US20030153577 Cyclic amine derivatives-CCR-3 receptor antagonists
08/14/2003US20030153553 Quinoline derivatives
08/14/2003CA2475141A1 Process for the synthesis of n-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids
08/14/2003CA2474214A1 Novel aryl- and heteroarylpiperazines
08/14/2003CA2473181A1 Quinoline derivatives as npy antagonists
08/13/2003EP1334967A1 Process for producign optically active ethyl (3r,5s,6e)-7- 2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-6-heptenoate
08/13/2003EP1334089A1 Quinoline derivatives as nk-3 and nk-2 antagonists
08/13/2003EP1334088A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
08/13/2003EP1334085A1 Sulfamides as gamma-secretase inhibitors
08/13/2003EP1334083A2 1,4-disubstituted benzenes as insecticides
08/13/2003EP1333831A2 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors
1 ... 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... 277